关键词: contact allergy dynamic OCT noninvasive diagnostics optical coherence tomography (OCT) patch-test grading

Mesh : Algorithms Animals Dermatitis, Allergic Contact / diagnosis diagnostic imaging pathology Dermatitis, Irritant / diagnosis diagnostic imaging pathology Diagnosis, Differential Epidermis / pathology Humans Patch Tests Prospective Studies Regional Blood Flow Skin / blood supply diagnostic imaging pathology Tomography, Optical Coherence

来  源:   DOI:10.1111/cod.13714   PDF(Sci-hub)

Abstract:
BACKGROUND: The diagnosis of allergic contact dermatitis should be confirmed by skin patch tests. Distinguishing between irritant and allergic reactions is sometimes difficult.
OBJECTIVE: To analyse the in vivo morphological changes in patch test reactions compared to healthy skin, and to detect subclinical changes in doubtful reactions using optical coherence tomography (OCT). To develop an OCT-based algorithm to support patch-test grading.
METHODS: One hundred twenty-nine skin patch-test areas were scanned with OCT to evaluate the following features: architectural and vascular morphology, epidermal thickness, optical attenuation coefficient (AC), and blood flow at 0.1, 0.2, and 0.35 mm depth.
RESULTS: Most common OCT features of acute contact allergic reactions in patch tests were spongiosis with microvesicles (94.8%), macrovesicles (60.3%), and coalescing vesicles (46.6%), the latter useful in differentiating acute allergic from irritant dermatitis (P-value < .05). Objective quantitative parameters correlated well with the severity grade: epidermal thickness due to spongiosis, AC (P-value < .05) and blood flow at 0.2 and 0.35 mm (P-value < .01).
CONCLUSIONS: OCT as a noninvasive diagnostic tool, established for skin cancer diagnosis, is useful for evaluating contact allergic patch-test reactions. Not only morphological but also objective features such as blood flow and AC correlate with the reaction severity. Further studies are needed to explore the differences in irritant and allergic contact dermatitis.
摘要:
暂无翻译
公众号